Celgene Executive Chairman Hugin to retire

Celgene Corp. (NASDAQ:CELG) said Bob Hugin will retire as executive chairman and step down from its board, effective Feb. 5. CEO Mark Alles will succeed as chairman.

Hugin has been at Celgene for 19 years and served as CEO from 2010 until Alles took the torch in March 2016. Under Hugin's leadership, the company said it achieved double-digit increases in net product sales and adjusted diluted EPS each year, received approvals for eight therapies across 10 diseases and tripled its headcount since 2010 to 7,500 employees...